These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


413 related items for PubMed ID: 16772159

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Polycystic ovary syndrome, obesity and reproductive implications.
    Hirschberg AL.
    Womens Health (Lond); 2009 Sep; 5(5):529-40; quiz 541-2. PubMed ID: 19702452
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Prevention of diabetes and cardiovascular disease in women with PCOS: treatment with insulin sensitizers.
    Sharma ST, Nestler JE.
    Best Pract Res Clin Endocrinol Metab; 2006 Jun; 20(2):245-60. PubMed ID: 16772155
    [Abstract] [Full Text] [Related]

  • 26. Exercise therapy in polycystic ovary syndrome.
    Hoeger KM.
    Semin Reprod Med; 2008 Jan; 26(1):93-100. PubMed ID: 18181087
    [Abstract] [Full Text] [Related]

  • 27. Insulin resistance syndrome and polycystic ovary syndrome: implications for diagnosis and treatment.
    Tan S, Hahn S, Janssen OE.
    Panminerva Med; 2005 Dec; 47(4):211-7. PubMed ID: 16489320
    [Abstract] [Full Text] [Related]

  • 28. PCOS in adolescents.
    Diamanti-Kandarakis E.
    Best Pract Res Clin Obstet Gynaecol; 2010 Apr; 24(2):173-83. PubMed ID: 19932060
    [Abstract] [Full Text] [Related]

  • 29. Polycystic ovary syndrome: pathophysiology, molecular aspects and clinical implications.
    Nardo LG, Patchava S, Laing I.
    Panminerva Med; 2008 Dec; 50(4):267-78. PubMed ID: 19078868
    [Abstract] [Full Text] [Related]

  • 30. Treatment of infertility in the polycystic ovary syndrome.
    Panidis D, Farmakiotis D.
    N Engl J Med; 2007 May 10; 356(19):1999; author reply 2000-1. PubMed ID: 17494937
    [No Abstract] [Full Text] [Related]

  • 31. Stress in women: metabolic syndrome and polycystic ovary syndrome.
    Diamanti-Kandarakis E, Economou F.
    Ann N Y Acad Sci; 2006 Nov 10; 1083():54-62. PubMed ID: 17148733
    [Abstract] [Full Text] [Related]

  • 32. Metabolic and cardiovascular consequences of polycystic ovary syndrome.
    Orio F, Vuolo L, Palomba S, Lombardi G, Colao A.
    Minerva Ginecol; 2008 Feb 10; 60(1):39-51. PubMed ID: 18277351
    [Abstract] [Full Text] [Related]

  • 33. Long-term metabolic, cardiovascular and neoplastic risks with polycystic ovary syndrome.
    Cattrall FR, Healy DL.
    Best Pract Res Clin Obstet Gynaecol; 2004 Oct 10; 18(5):803-12. PubMed ID: 15380148
    [Abstract] [Full Text] [Related]

  • 34. Polycystic ovarian syndrome: the commonest cause of hyperandrogenemia in women as a risk factor for metabolic syndrome.
    Diamanti-Kandarakis E, Christakou C, Kandarakis H.
    Minerva Endocrinol; 2007 Mar 10; 32(1):35-47. PubMed ID: 17353865
    [Abstract] [Full Text] [Related]

  • 35. The management of insulin resistance in polycystic ovary syndrome.
    Teede HJ, Hutchison SK, Zoungas S.
    Trends Endocrinol Metab; 2007 Sep 10; 18(7):273-9. PubMed ID: 17698366
    [Abstract] [Full Text] [Related]

  • 36. Ovulation induction management of PCOS.
    Guzick DS.
    Clin Obstet Gynecol; 2007 Mar 10; 50(1):255-67. PubMed ID: 17304040
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Polycystic ovary syndrome: a multifaceted disease from adolescence to adult age.
    Pasquali R, Gambineri A.
    Ann N Y Acad Sci; 2006 Dec 10; 1092():158-74. PubMed ID: 17308142
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 21.